Watch Demo

Norway Anti-Infective Industry Outlook 2024 - 2028

See how Norway Anti-Infective performed compared to key markets such as Italy, Spain and Croatia.

Key Market Indicators

**Norwegian Antiinfective Medicine Market to Hit $297 Million by 2028** The Norwegian antiinfective medicine market is projected to grow marginally from $293 million in 2023 to $297 million by 2028, representing a compound annual growth rate (CAGR) of 0.2%. Over the past 15 years, the market has seen a steady increase, averaging a 1.6% growth year on year since 2008. In the global ranking for 2023, Norway holds the 10th position, with Austria slightly ahead, also at $293 million. Leading the list are Spain, Croatia, and Australia, occupying the second, third, and fourth positions, respectively. **Surge in Norwegian Antibiotics Export** Norwegian antibiotics exports experienced a significant surge, reaching $19,120 in 2018, up from $6,160 in 2017. This marks a substantial increase of 210.3% compared to the previous year. Despite this recent growth, the long-term trend shows a steep decline, with a 75.5% year-on-year decrease since 1998. **Rise in Norwegian Antibiotics Import** On the import front, Norway's antibiotics imports climbed to $323,010 in 2018, up from $225,990 in 2017, reflecting a robust growth of 42.9% year on year. However, this increase comes amid a long-term downward trend, with a 16.7% decrease in imports since 1998.

Marketing Banner

Norway Anti-Infective Market Data and Forecasts

How much will Norway Anti-Infective Market grow to 2028?

Forecast: Import of Resorcinol to Norway
Forecast: Import of Benzyl Alcohol to Norway
Forecast: Import of Benzyl Alcohol to Norway
Forecast: Import of Resorcinol to Norway
More in Anti-Infective Industry for 2028